AR030715A1 - Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones - Google Patents

Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones

Info

Publication number
AR030715A1
AR030715A1 ARP010104207A ARP010104207A AR030715A1 AR 030715 A1 AR030715 A1 AR 030715A1 AR P010104207 A ARP010104207 A AR P010104207A AR P010104207 A ARP010104207 A AR P010104207A AR 030715 A1 AR030715 A1 AR 030715A1
Authority
AR
Argentina
Prior art keywords
flavored
mixtures
pharmaceutical compositions
flavoring
flavoring systems
Prior art date
Application number
ARP010104207A
Other languages
English (en)
Inventor
Laman Alani
Donald Gauwitz
Dilip Kaul
John Lipari
Keenan Marsh
Richard Whelan
Vanik Petrossian
Soumojeet Ghosh
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of AR030715A1 publication Critical patent/AR030715A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)

Abstract

Sistemas saborizantes para una composicion farmacéutica líquida y composiciones farmacéuticas que contienen dichos sistemas saborizantes. Los sistemas saborizantes de la invencion incluyen por lo menos un agente edulcorante, por lo menos dos ingredientes con sabor, y por lo menos un modificador del sabor que se selecciona entre el grupo que consiste en ácido cítrico, citrato de sodio, cloruro de sodio y mezclas de los mismos. Por lo menos dos de los ingredientes saborizados se seleccionan entre el grupo que consiste en un ingrediente con sabor a vainilla, un ingrediente con sabor a menta, un ingrediente con sabor a mentol, un ingrediente con sabor a algodon de azucar, y mezclas de los mismos. El (los) agente(s) edulcorante(s) comprende(n) glicerina, glicirricinato de monoamonio, sacarina sodica, acesulfame potásico, jarabe de maíz de alta fructosa, y/o mezclas de los mismos. Las composiciones farmacéuticas de la invencion incluyen un sistema saborizante de la invencion, un sistema solvente, y por lo menos un agente farmacéuticamente activo, como por ejemplo lopinavir o derivados del mismo, ritonavir o derivados del mismo, o mezclas de los mismos. También se describen métodos para hacer dichas composiciones farmacéuticas líquidas.
ARP010104207A 2000-09-05 2001-09-04 Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones AR030715A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65519200A 2000-09-05 2000-09-05

Publications (1)

Publication Number Publication Date
AR030715A1 true AR030715A1 (es) 2003-09-03

Family

ID=24627898

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010104207A AR030715A1 (es) 2000-09-05 2001-09-04 Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones

Country Status (10)

Country Link
EP (1) EP1315487A2 (es)
JP (1) JP2004522698A (es)
AR (1) AR030715A1 (es)
AU (1) AU2001288695A1 (es)
BR (1) BR0108433A (es)
CA (1) CA2417258A1 (es)
MX (1) MXPA03001952A (es)
PE (1) PE20020373A1 (es)
UY (1) UY26925A1 (es)
WO (1) WO2002020057A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175205B1 (en) 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
AU2003295589A1 (en) * 2002-11-22 2004-06-18 Noville, Inc. Oral compositions which mask the salty taste of salts
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
WO2013129436A1 (ja) * 2012-02-29 2013-09-06 武田薬品工業株式会社 経口剤
US8771651B2 (en) * 2012-09-10 2014-07-08 Johnson & Johnson Consumer Companies, Inc. Mouth rinses and tooth sensitivity treatment compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111991A (en) * 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
WO1997046222A1 (en) * 1996-06-03 1997-12-11 Merck & Co., Inc. Pediatric formulation for hiv protease inhibitors

Also Published As

Publication number Publication date
BR0108433A (pt) 2006-06-06
CA2417258A1 (en) 2002-03-14
AU2001288695A1 (en) 2002-03-22
PE20020373A1 (es) 2002-05-13
MXPA03001952A (es) 2003-09-10
WO2002020057A3 (en) 2002-05-10
JP2004522698A (ja) 2004-07-29
WO2002020057A2 (en) 2002-03-14
UY26925A1 (es) 2002-04-26
EP1315487A2 (en) 2003-06-04

Similar Documents

Publication Publication Date Title
CY1114631T1 (el) Φαρμακοτεχνικες μορφες εχινοκανδινης που περιεχουν επιφανειοδραστικα που σχηματιζουν μικκυλιο
BR0010984A (pt) Matrizes porosas de medicamento e processos para fabricação das mesmas
AR073793A1 (es) Formulacion farmaceutica liquida que contiene paracetamol. excipiente liquido
TR200002812T2 (tr) Efervesan formülasyonları.
ITMI20021392A1 (it) Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
WO2005020962A8 (en) Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
CO5560580A2 (es) Formulaciones de sucralosa para disumular sabores desagradables
UA79196C2 (en) Intranasal formulation of rotigotine
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
DK342989A (da) Betaendelseshaemmende middel
AR030715A1 (es) Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones
PE20030545A1 (es) Formulaciones de jarabe de ribavirina
AR023138A1 (es) Composicion para gomas de mascar medicadas, proceso de fabricacion y tabletas obtenidas con dicho proceso
ES2312921T3 (es) Disolucion acuosa concentrada de ambroxol.
AR006345A1 (es) Una composicion farmaceutica para administracion oral que comprende un inhibidor de proteasa del vih y un derivado de tocoferol soluble en agua, y un metodo para preparar dicha composicion.
WO2004069187A3 (en) Drug formulation and delivery using crystalline methylated cyclodextrins
ES2310550T3 (es) Preparacion liquida acuosa de pranoprofeno.
BR0302523A (pt) Composição farmacêutica estável para administração de inibidores da hiv protease e processo de obtenção de composição farmacêutica concentrada para a administração de inibidores da hiv protease
CO4970788A1 (es) Formulaciones orales para drogas hidrofilicas
JP2007008852A (ja) プラバスタチンを含有する水性製剤の安定化方法
TH51212A (th) ระบบแต่งรสชาติสำหรับองค์ประกอบทางเภสัชกรรมและวิธีการเตรียมองค์ประกอบดังกล่าว
CA2954392A1 (en) Diclofenac sublingual spray
BR0202252A (pt) Composição farmacêutica solúvel estável para administração de inibidores da hiv protease e processo de obtenção de composições farmacêuticas concentradas para a administração de inibidores da hiv protease
JP2003055247A (ja) 内服用液剤

Legal Events

Date Code Title Description
FB Suspension of granting procedure